Determination of glycine in the pharmaceutical of human coagulation factor Ⅷ by HPLC
doi: 10.3969/j.issn.1006-0111.2016.01.016
- Received Date: 2015-06-20
- Rev Recd Date: 2015-10-30
-
Key words:
- human coagulation factor Ⅷ /
- glycine /
- alanine /
- HPLC /
- determination
Abstract: Objective To establish the method for determination content of glycine in the pharmaceutical of human coagulation factor Ⅷ by HPLC. Methods The analysis was carried on a Shim-Pack CLC-ODS column with a mobile phase of 50% acetonitrile -0.05 mol/L sodium acetate buffer (35:65) at the detection wavelength of 360 nm, using alanine and 2,4-dinitrofluorobenzene as the internal standard and derivation agent, respectively. Results The method showed a good linearity in the range of 0.006-0.030 mg/ml (r=0.999 3) for glycine. The average recovery was 101.4%, and the RSD was 0.14% (n=9). Conclusion This method was simple, sensitive, accurate, reliable, and suitable for determination of glycine in the pharmaceutical of human coagulation factor Ⅷ.
Citation: | GAO Liping, LI Ping, YAO Jiajia. Determination of glycine in the pharmaceutical of human coagulation factor Ⅷ by HPLC[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(1): 59-61. doi: 10.3969/j.issn.1006-0111.2016.01.016 |